Dr. Nasser Al-Dawood, undersecretary of the Saudi Ministry of Interior

Dr. Nasser Al-Dawood, undersecretary of the Saudi Ministry of Interior
Short Url
Updated 25 November 2020

Dr. Nasser Al-Dawood, undersecretary of the Saudi Ministry of Interior

Dr. Nasser Al-Dawood, undersecretary of the Saudi Ministry of Interior

Dr. Nasser bin Abdul Aziz Al-Dawood has been the undersecretary of the Ministry of Interior at the rank of minister since 2018.
On Saturday, Al-Dawood handed out prizes to 20 winners of the Absherthon incubator challenge which aims to encourage creativity and enhance the ministry’s e-services.
He joined the faculty of Shariah at Imam Muhammad bin Saud Islamic University and gained a bachelor’s degree in 1976-1977. He became a lecturer in the university’s faculty of social sciences in 1978.
Al-Dawood then went to the US and obtained a master’s degree and doctorate in education curriculum and teaching methods from the University of Northern Colorado.
After gaining his doctorate, he served as an assistant professor in the department of education at the faculty of social sciences at Imam Muhammad bin Saud Islamic University in 1983.
The following year, he became an associate professor in the department of education and was dean of the university’s faculty of social sciences in 1988.
Al-Dawood became director general of education in Riyadh in December 1991, serving in the role until August 1993.
He has been undersecretary of Riyadh since 2005 and was appointed as undersecretary of the Ministry of Interior in June 2018 while serving as a member of the Shoura Council.
King Salman issued a royal decree to appoint Al-Dawood as an adviser to the royal court.
He was also given the job of overseeing the celebrations for the 100th anniversary of the Kingdom’s founding, in the position of a secretary-general to the acting committee.
Al-Dawood has taken part in a number of conferences and events inside and outside of Saudi Arabia and has had research and study papers published in a range of scientific journals.


Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
Updated 16 January 2021

Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
  • It will go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority

RIYADH: Preclinical studies on the first Saudi vaccine against COVID-19 have been completed.

Professor of epidemiology Dr. Iman Almansour, who heads the team of researchers working on the vaccine at the Institute for Research and Medical Consultations (IRMC), affiliated with Imam Abdulrahman Bin Faisal University (IAU), confirmed to Arab News on Friday that the studies were complete, and said clinical trials would begin as soon as “the proper approvals” had been given.

She did not specify when that is expected to happen.

The Ministry of Education is financing the team’s project. The team’s research paper has been published in the peer-reviewed journal Pharmaceuticals.

The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen.

Dr. Iman Almansour, professor of epidemiology

According to the published paper, the vaccine has so far proven effective, when used on animals, in eliciting antibodies that will target the virus. “The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen,” Dr. Almansour explained.

Dr. Turki Almugaiteeb, director of Healthcare and Life Sciences at RPD Innovations, which runs the National Vaccine and Biomanufacturing Center, told Arab News: “There is a great focus on the results of medical research because of the pandemic. Research can play a great role in developing a vaccine that can be adopted and further developed in the future. We can say that the Kingdom has a strong infrastructure, which can help produce and manufacture a national vaccine.”

Both Almugaiteeb and Almansour stressed that the experimental vaccine will need to go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority.

Prof. Nasser Al-Aqeeli, the deputy minister of education for research and innovation, said the ministry supported programs at the Kingdom’s universities with more than SR500 million ($133.3 million) in 2020.